76 results
Page 2 of 4
424B5
z00pvps0
23 Aug 22
Prospectus supplement for primary offering
4:30pm
424B4
xs0tz igiu
5 Jul 22
Prospectus supplement with pricing info
4:26pm
8-K
EX-1.1
4g306 37t8zkqay
27 Apr 22
Agile Therapeutics Announces 1-FOR-40 Reverse Stock Split
7:21am
424B5
nmx99e67 6o
27 Apr 22
Prospectus supplement for primary offering
6:30am
424B5
63ac5l0
14 Mar 22
Prospectus supplement for primary offering
5:26pm
8-K
EX-1.1
rvzpxlaxv24itd1i8ln
10 Jan 22
Entry into a Material Definitive Agreement
8:05am
8-K
EX-99.1
i280 3w2ts3bntb77g
10 Jan 22
Entry into a Material Definitive Agreement
8:05am
424B5
w1v jg6ga
10 Jan 22
Prospectus supplement for primary offering
8:00am
8-K
EX-99.1
wq8kubb
2 Nov 21
Agile Therapeutics Reports Third Quarter 2021 Financial Results
4:11pm
424B5
c2il j51h
8 Oct 21
Prospectus supplement for primary offering
5:21pm
424B5
skyuq498n4
7 Oct 21
Prospectus supplement for primary offering
5:24pm
8-K
EX-99.1
ho5er1ba
4 Oct 21
Agile Therapeutics Announces Addition of Twirla® to a Preferred Drug Position on Medi-Cal Formulary
4:30pm